ATE284710T1 - Adjuvans für vitale impfstoffe - Google Patents

Adjuvans für vitale impfstoffe

Info

Publication number: ATE284710T1
Authority: AT; Austria
Prior art keywords: adjuvans; vaccines; vital; adjuvant; compositions
Prior art date: 1995-06-02

Application number

AT96303835T

Other languages

English (en)

Inventor

Richard Norman Hjorth

Original Assignee

Wyeth Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-06-02

Filing date

1996-05-29

Publication date

2005-01-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23825435&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE284710(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1996-05-29 Application filed by Wyeth Corp filed Critical Wyeth Corp

2005-01-15 Application granted granted Critical

2005-01-15 Publication of ATE284710T1 publication Critical patent/ATE284710T1/de

Links

239000002671 adjuvant Substances 0.000 title abstract 3
229960005486 vaccine Drugs 0.000 title abstract 2
PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 abstract 3
239000000203 mixture Substances 0.000 abstract 2
YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 abstract 1
BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 abstract 1
159000000013 aluminium salts Chemical class 0.000 abstract 1
229910000329 aluminium sulfate Inorganic materials 0.000 abstract 1
239000000872 buffer Substances 0.000 abstract 1
PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 abstract 1
229940031439 squalene Drugs 0.000 abstract 1
TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 abstract 1
239000004094 surface-active agent Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Mycology (AREA)
Epidemiology (AREA)
Immunology (AREA)
Medicinal Chemistry (AREA)
Microbiology (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicinal Preparation (AREA)

AT96303835T 1995-06-02 1996-05-29 Adjuvans für vitale impfstoffe ATE284710T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US08/459,600 US5718904A (en)	1995-06-02	1995-06-02	Adjuvants for viral vaccines

Publications (1)

Publication Number	Publication Date
ATE284710T1 true ATE284710T1 (de)	2005-01-15

Family

ID=23825435

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT96303835T ATE284710T1 (de)	1995-06-02	1996-05-29	Adjuvans für vitale impfstoffe

Country Status (13)

Country	Link
US (1)	US5718904A (de)
EP (1)	EP0745387B1 (de)
JP (1)	JP4344017B2 (de)
KR (1)	KR970000248A (de)
CN (1)	CN1141810A (de)
AT (1)	ATE284710T1 (de)
AU (1)	AU712972B2 (de)
CA (1)	CA2177668C (de)
DE (1)	DE69634024T2 (de)
DK (1)	DK0745387T3 (de)
ES (1)	ES2233955T3 (de)
HU (1)	HUP9601466A2 (de)
NZ (1)	NZ286699A (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
PT973546E (pt) *	1997-04-08	2004-06-30	Merck & Co Inc	Formulacoes estabilizadas de virus de papiloma humano
US6165481A (en) *	1997-12-25	2000-12-26	Nippon Petrochemicals Company, Inc.	Highly pure squalane, raw material for pharmaceuticals and cosmetics prepared by using the same and method for producing the same
AU769539B2 (en)	1999-01-29	2004-01-29	Zoetis Services Llc	Adjuvants for use in vaccines
AU2004226591B2 (en) *	2003-04-04	2009-06-04	Zoetis Services Llc	Microfluidized oil-in-water emulsions and vaccine compositions
KR20110132416A (ko)	2004-04-05	2011-12-07	화이자 프로덕츠 인코포레이티드	미세유체화된 수중유 유화액 및 백신 조성물
CN1315533C (zh) *	2004-06-24	2007-05-16	上海市农业科学院畜牧兽医研究所	猪细小病毒油乳剂灭活疫苗
US20060228369A1 (en) *	2005-04-11	2006-10-12	Program For Appropriate Technology In Health	Stabilization and preservation of temperature-sensitive vaccines
DK1909830T3 (da) *	2005-08-02	2011-12-19	Novartis Vaccines & Diagnostic	Formindskelse af interferens mellem olieholdige adjuvanser og antigener indeholdende overfladeaktivt middel
FR2896162B1 (fr) *	2006-01-13	2008-02-15	Sanofi Pasteur Sa	Emulsion huile dans eau thermoreversible
CA2634888C (en) *	2006-01-26	2016-06-21	Pfizer Products Inc.	Novel glycolipid adjuvant compositions
US7682619B2 (en) *	2006-04-06	2010-03-23	Cornell Research Foundation, Inc.	Canine influenza virus
ITFI20060163A1 (it) *	2006-06-29	2006-09-28	Menarini Internat Operations Luxembourg Sa	Composizione farmaceutica contenente un anticorpo monoclonale anti idiotipico anti-ca-125 ed alluminio
PL2068918T5 (pl)	2006-09-26	2024-12-02	Access To Advanced Health Institute	Kompozycja szczepionki zawierająca syntetyczny adiuwant
US20090181078A1 (en)	2006-09-26	2009-07-16	Infectious Disease Research Institute	Vaccine composition containing synthetic adjuvant
GB0622282D0 (en)	2006-11-08	2006-12-20	Novartis Ag	Quality control methods
CA2764374C (en)	2009-06-05	2019-11-19	Infectious Disease Research Institute	Synthetic glucopyranosyl lipid adjuvants
US20110305748A1 (en)	2010-03-11	2011-12-15	Immune Design, Corp.	Vaccines for Pandemic Influenza
EA027236B1 (ru)	2011-04-08	2017-07-31	Иммьюн Дизайн Корп.	Иммуногенные композиции и способы применения таких композиций для индукции гуморального и клеточного иммунного ответа
US20120288515A1 (en)	2011-04-27	2012-11-15	Immune Design Corp.	Synthetic long peptide (slp)-based vaccines
HRP20181102T1 (hr)	2012-05-16	2018-09-07	Immune Design Corp	Cjepiva za hsv-2
CN102764431B (zh) *	2012-08-03	2014-10-22	江苏省农业科学院	一种猪支原体肺炎雾化活疫苗及其制备与检验方法
CN104043119B (zh) *	2013-03-13	2016-05-25	上海医药工业研究院	一种新型疫苗佐剂及其制备方法
MX370573B (es)	2013-04-18	2019-12-17	Immune Design Corp	Monoterapia con glucopiranosil lipido a para usarse en el tratamiento del cancer.
US9463198B2 (en)	2013-06-04	2016-10-11	Infectious Disease Research Institute	Compositions and methods for reducing or preventing metastasis
US10653766B2 (en)	2014-03-12	2020-05-19	Bavarian Nordic A/S	Use of oil and water emulsions for increasing B cell responses with modified Vaccinia Ankara virus
EP3843782A1 (de)	2018-08-29	2021-07-07	Centre Hospitalier Universitaire Vaudois (CHUV)	Ebolaimpfstoffzusammensetzungen und verfahren zu ihrer verwendung

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4073743A (en) *	1975-04-17	1978-02-14	Merck & Co., Inc.	Process for preparing an emulsion
US4466957A (en) *	1982-02-25	1984-08-21	American Home Products Corporation	Vaccine adjuvants
DE3446515A1 (de) *	1984-12-20	1986-06-26	Behringwerke Ag, 3550 Marburg	Oeladjuvierte vaccine und verfahren zu ihrer herstellung
US4806352A (en) *	1986-04-15	1989-02-21	Ribi Immunochem Research Inc.	Immunological lipid emulsion adjuvant
US4803070A (en) *	1986-04-15	1989-02-07	Ribi Immunochem Research Inc.	Immunological emulsion adjuvants for polysaccharide vaccines
US5376369A (en) *	1987-11-03	1994-12-27	Syntex (U.S.A.) Inc.	Vaccine adjuvant
CA2017507C (en) *	1989-05-25	1996-11-12	Gary Van Nest	Adjuvant formulation comprising a submicron oil droplet emulsion

1995
- 1995-06-02 US US08/459,600 patent/US5718904A/en not_active Expired - Lifetime
1996
- 1996-05-16 JP JP12143896A patent/JP4344017B2/ja not_active Expired - Lifetime
- 1996-05-29 AT AT96303835T patent/ATE284710T1/de active
- 1996-05-29 ES ES96303835T patent/ES2233955T3/es not_active Expired - Lifetime
- 1996-05-29 CA CA002177668A patent/CA2177668C/en not_active Expired - Lifetime
- 1996-05-29 AU AU54575/96A patent/AU712972B2/en not_active Expired
- 1996-05-29 DK DK96303835T patent/DK0745387T3/da active
- 1996-05-29 EP EP96303835A patent/EP0745387B1/de not_active Revoked
- 1996-05-29 DE DE69634024T patent/DE69634024T2/de not_active Expired - Lifetime
- 1996-05-30 NZ NZ286699A patent/NZ286699A/en not_active IP Right Cessation
- 1996-05-30 HU HU9601466A patent/HUP9601466A2/hu unknown
- 1996-05-31 KR KR1019960018975A patent/KR970000248A/ko not_active Ceased
- 1996-06-01 CN CN96110402A patent/CN1141810A/zh active Pending

Also Published As

Publication number	Publication date
CN1141810A (zh)	1997-02-05
JP4344017B2 (ja)	2009-10-14
CA2177668A1 (en)	1996-12-03
EP0745387A2 (de)	1996-12-04
HUP9601466A2 (en)	1997-03-28
KR970000248A (ko)	1997-01-21
DE69634024T2 (de)	2005-12-08
HU9601466D0 (en)	1996-07-29
CA2177668C (en)	2009-02-24
EP0745387A3 (de)	1998-03-11
NZ286699A (en)	1997-10-24
US5718904A (en)	1998-02-17
AU5457596A (en)	1996-12-12
EP0745387B1 (de)	2004-12-15
DK0745387T3 (da)	2005-02-21
JPH08325163A (ja)	1996-12-10
ES2233955T3 (es)	2005-06-16
DE69634024D1 (de)	2005-01-20
AU712972B2 (en)	1999-11-18

Legal Events

Date

Code

Title

Description

2005-10-15

UEP

Publication of translation of european patent specification

Ref document number: 0745387

Country of ref document: EP

Publication	Publication Date	Title
DE69634024D1 (de)	2005-01-20	Adjuvans für vitale Impfstoffe
HU9601462D0 (en)	1996-07-29	Adjuvants for viral vaccines
NO982497L (no)	1998-06-02	Vaksine-sammensetninger for inntak gjennom nesen
NO975620D0 (no)	1997-12-04	Immunologiske kombinasjonssammensetninger og fremgangsmåter
IT1229845B (it)	1991-09-13	Procedimento per la preparazione di perfluoropolieteri perossidici.
IT8722481A0 (it)	1987-11-02	Polipeptidi immunologicamente attivi con una tossicita' alterata utili per la preparazione di un vaccino antipertosse.
PT789590E (pt)	2002-12-31	Imunopotenciacao induzida por quitosano
PT939648E (pt)	2008-01-11	Formulações de vacinas de rotavírus
IT1272345B (it)	1997-06-16	"procedimento per la levigatura dello spigolo di fette di semiconduttori".
FI20070041L (fi)	2007-01-17	Parannettu rokote Flavivirusinfektioiden vastaiseen immuunisointiin
IT1269916B (it)	1997-04-16	Procedimento migliorato per la sintesi di dimetilcarbonato
ITMI931680A0 (it)	1993-07-28	Procedimento per la preparazione di alcansolfonammidi
IT8919049A0 (it)	1989-01-10	Procedimento per la preparazione di fluoxetina cloridrato.
FI894653A0 (fi)	1989-10-02	Stabila oxapenem-3-karboxylsyror och deras anvaendning som b-laktamasfoerhindrare.
SE9604322D0 (sv)	1996-11-25	Bacterial antigens and vaccine compositions II
GB9018061D0 (en)	1990-10-03	Compositions for vaccines
IT1240470B (it)	1993-12-17	Procedimento per la preparazione di un gel di poliacrilato di sodio.
ZA997265B (en)	2001-05-23	Leptospira vaccine antigens for the prevention of leptospirosis.
ITMI930520A1 (it)	1994-09-19	Procedimento per la preparazione di disperdenti solfonati.
ITTO940505A0 (it)	1994-06-17	Procedimento per l'attuazione di microgiunti e macchina per l'attuazione di tale procedimento.
ITRM920074A0 (it)	1992-02-03	Procedimento per la preparazione di vaccini, e vaccini cosi' ottenibili.
ITMI930340A1 (it)	1994-08-23	Procedimento per la preparazione di 5-oxo-2-pirrolidoncarbossilato di piridossina
ITMI922378A1 (it)	1994-04-16	Procedimento per la stabilizzazione di residui e bitumi.
ITMI932694A0 (it)	1993-12-22	Procedimento per la preparazione di 2-idrossi-1-4-noftochinoni
ITTO920591A0 (it)	1992-07-10	Procedimento per la preparazione di n-fosfonometilglicina.